Cargando…
Short‐term and long‐term effects of cryoballoon ablation versus antiarrhythmic drug therapy as first‐line treatment for paroxysmal atrial fibrillation: A systematic review and meta‐analysis
Cryoballoon ablation (CBA) is an effective treatment for drug‐refractory atrial fibrillation (AF) patients. Whether CBA as a first‐line treatment is superior in the rhythm control of AF than antiarrhythmic drugs (AAD) remains unclear. CBA is superior to AAD as initial therapy for rhythm control of p...
Autores principales: | Liu, Zirui, Yang, Zhengkai, Lu, Yu, Wang, Haocheng, Zou, Cao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577536/ https://www.ncbi.nlm.nih.gov/pubmed/37469293 http://dx.doi.org/10.1002/clc.24092 |
Ejemplares similares
-
Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation
por: Kuniss, Malte, et al.
Publicado: (2021) -
An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from an English NHS perspective
por: Andrade, J, et al.
Publicado: (2023) -
Cryoballoon Ablation for Patients With Paroxysmal Atrial Fibrillation
por: Suenari, Kazuyoshi, et al.
Publicado: (2020) -
An economic evaluation of first-line cryoballoon ablation vs antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a U.S. Medicare perspective
por: Wazni, Oussama, et al.
Publicado: (2023) -
Meta‐analysis of cryoballoon ablation versus antiarrhythmic drugs as initial therapy for symptomatic atrial fibrillation
por: Mao, Yin‐jun, et al.
Publicado: (2021)